LinkMed’s portfolio company Likvor receives new order for Likvor CELDA

LinkMed’s (STO:LMED) portfolio company Likvor has received a new order for Likvor CELDA™ ,this time from Sahlgrenska University Hospital in Gothenburg. With Likvor CELDA™ the clinical will be able to dynamic measure the most important parameters concerning the patients’ cerebrospinal fluid including pressure and flow in a controlled and safe process. Likvor CELDATM was developed to facility greater understanding and enhancing diagnosis of normal pressure hydrocephalus (NPH), a condition that is often mistaken for dementia. This is the third order for the instrument since it got CE marked.

Likvor CELDA™ is the first commercially approved instrument for assessing the flow of CSF fluid that surrounds the brain and spinal cord. It increases the possibility for patients who suffer from NPH to receive a correct diagnosis and therefore the appropriate treatment in the form of a shunt implant that diverts and regulates CSF pressure and flow. An accurate diagnosis means large gains for the patient and family, but also for society as a whole.

Likvor CELDA™ is used with a special developed catheter, CELDA TOOLS™ that is a disposable for one time use only.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Meningitis case at Children's National Hospital raises concerns about antibiotic resistance